Associations between cardiovascular-kidney-metabolic syndrome staging and risks of all-cause and cardiovascular mortality: a systematic review and meta-analysis
American Journal of Preventive Cardiology · 2026-02 · 25 · 101407
DOI: 10.1016/j.ajpc.2026.101407 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift American Journal of Preventive Cardiology, 2026-02. Verfasst von Huimin Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Physical Education, Myongji University, Yongin 17058, , Republic of Korea. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiovascular, kidney, and metabolic disorders are closely interconnected and jointly increase atherosclerotic burden and mortality risk. In 2023, the American Heart Association introduced the cardiovascular-kidney-metabolic (CKM) syndrome as a staged framework to characterize this multisystem risk. However, evidence linking CKM stages to mortality has not yet been quantitatively synthesized.
Methods
We conducted a PROSPERO-registered (CRD420251161180) systematic review and meta-analysis following MOOSE and PRISMA guidelines. Four databases (PUBMED,Web of science, Embase, Cochrane library)were searched through August 8, 2025. Cohort studies assessing CKM stages (0-4) and reporting all-cause, cardiovascular disease (CVD), coronary heart disease (CHD), or stroke mortality were synthesized using random-effects models, with subgroup, meta-regression, and sensitivity analyses.
Results
9 cohort studies including 10,330,498 participants were analyzed. Mortality risk increased significantly with advancing CKM stages. Compared with Stage 0, Stage 4 was associated with markedly higher risks of all-cause mortality (HR = 3.82, 95% CI: 2.24-6.52), CVD mortality (HR = 6.38, 95% CI: 5.22-7.80), CHD mortality (HR = 9.19, 95% CI: 6.93-12.20), and stroke mortality (HR = 5.48, 95% CI: 4.28-7.02). Meta-regression identified age and educational attainment as significant effect modifiers and sources of heterogeneity. In sex-stratified analyses, all-cause mortality was consistently higher in women across CKM stages, whereas CVD mortality was higher in women at earlier stages but higher in men at later stages. Leave-one-out (LOO) sensitivity analyses and publication bias assessments supported the robustness of these findings.
Conclusions
Advancing CKM stages are associated with progressively higher mortality risks, highlighting their value for early risk assessment and targeted prevention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School of Physical Education, Myongji University, Yongin 17058, , Republic of Korea.
- Waseda University, 1-104 Totsukamachi, Shinjuku-ku, Tokyo, 169-8050, Japan.
Zitieren
APA
Ding, H., Jiang, L., Zhao, Y., Lee, D., & Chun, B. (2026). Associations between cardiovascular-kidney-metabolic syndrome staging and risks of all-cause and cardiovascular mortality: a systematic review and meta-analysis. American Journal of Preventive Cardiology, 25, 101407. https://doi.org/10.1016/j.ajpc.2026.101407
Vancouver
Ding H, Jiang L, Zhao Y, Lee D, Chun B. Associations between cardiovascular-kidney-metabolic syndrome staging and risks of all-cause and cardiovascular mortality: a systematic review and meta-analysis. American Journal of Preventive Cardiology. 2026;25:101407. doi:10.1016/j.ajpc.2026.101407
BibTeX
@article{Ding2026,
author = {Ding, Huimin and Jiang, Liqun and Zhao, Yiqiu and Lee, Dongjun and Chun, Buongo},
title = {Associations between cardiovascular-kidney-metabolic syndrome staging and risks of all-cause and cardiovascular mortality: a systematic review and meta-analysis},
journal = {American Journal of Preventive Cardiology},
year = {2026},
volume = {25},
pages = {101407},
doi = {10.1016/j.ajpc.2026.101407}
}
EUVIMED